Published June 22, 2011 | Version v1
Journal article

Addressing Cancer Disparities Among American Indians through Innovative Technologies and Patient Navigation: The Walking Forward Experience

  • 1. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI (United States)
  • 2. Department of Oncology, John T. Vucurevich Cancer Care Institute, Rapid City, SD (United States)
  • 3. Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX (United States)
  • 4. Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD (United States)

Description

Purpose/Objective(s): American Indians (AIs) present with more advanced stages of cancer and, therefore, suffer from higher cancer mortality rates compared to non-AIs. Under the National Cancer Institute (NCI) Cancer Disparities Research Partnership (CDRP) Program, we have been researching methods of improving cancer treatment and outcomes since 2002, for AIs in Western South Dakota, through the Walking Forward (WF) Program. Materials/Methods: This program consists of (a) a culturally tailored patient navigation program that facilitated access to innovative clinical trials in conjunction with a comprehensive educational program encouraging screening and early detection, (b), surveys to evaluate barriers to access, (c) clinical trials focusing on reducing treatment length to facilitate enhanced participation using brachytherapy and intensity modulated radiotherapy (IMRT) for breast and prostate cancer, as AIs live a median of 140 miles from the cancer center, and (d) a molecular study (ataxia telangiectasia mutated) to address whether there is a specific profile that increases toxicity risks. Results: We describe the design and implementation of this program, summary of previously published results, and ongoing research to influence stage at presentation. Some of the critical outcomes include the successful implementation of a community-based research program, development of trust within tribal communities, identification of barriers, analysis of nearly 400 navigated cancer patients, clinical trial accrual rate of 10%, and total enrollment of nearly 2,500 AIs on WF research studies. Conclusion: This NCI funded pilot program has achieved some initial measures of success. A research infrastructure has been created in a community setting to address new research questions and interventions. Efforts underway to promote cancer education and screening are presented, as well as applications of the lessons learned to other health disparity populations – both nationally and internationally.

Availability note (English)

Available from http://dx.doi.org/10.3389/fonc.2011.00011

Additional details

Identifiers

Publishing Information

Journal Title
Frontiers in Oncology
Journal Volume
1
Journal Page Range
[9 p.]
ISSN
2234-943X

INIS

Country of Publication
Switzerland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
49035162
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRACHYTHERAPY; CLINICAL TRIALS; MAMMARY GLANDS; NAVIGATION; NEOPLASMS; PATIENTS; RADIATION HAZARDS; RESEARCH PROGRAMS
Descriptors DEC
BODY; DISEASES; GLANDS; HAZARDS; HEALTH HAZARDS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; TESTING; THERAPY

Optional Information

Copyright
Copyright (c) 2011 Petereit, Guadagnolo, Wong and Coleman.
Notes
This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.